A case-control auditory evaluation of patients treated with artemether-lumefantrine.
Toovey
Stephen
S
D000890:Anti-Infective Agents / Q000009:adverse effects*; D037621:Artemisinins / Q000009:adverse effects*; D001299:Audiometry; D001309:Auditory Threshold / Q000187:drug effects; D016022:Case-Control Studies; D004983:Ethanolamines / Q000009:adverse effects*; D005449:Fluorenes / Q000009:adverse effects*; D034381:Hearing Loss / Q000139:chemically induced*; D006801:Humans; D000078102:Lumefantrine; D008288:Malaria / Q000188:drug therapy; D012106:Research / Q000592:standards; D012717:Sesquiterpenes / Q000009:adverse effects*; D013997:Time Factors
D000890:Anti-Infective Agents; D037621:Artemisinins; D004983:Ethanolamines; D005449:Fluorenes; D012717:Sesquiterpenes; C031327:artemisinin; D000078102:Lumefantrine